| Literature DB >> 26703542 |
Tayser Sumer Gaaz1,2, Abu Bakar Sulong3, Majid Niaz Akhtar4,5, Abdul Amir H Kadhum6, Abu Bakar Mohamad7,8, Ahmed A Al-Amiery9.
Abstract
The aim of this review was to analyze/investigate the synthesis, properties, and applications of polyvinyl alcohol-halloysite nanotubes (PVA-HNT), and their nanocomposites. Different polymers with versatile properties are attractive because of their introduction and potential uses in many fields. Synthetic polymers, such as PVA, natural polymers like alginate, starch, chitosan, or any material with these components have prominent status as important and degradable materials with biocompatibility properties. These materials have been developed in the 1980s and are remarkable because of their recyclability and consideration of the natural continuation of their physical and chemical properties. The fabrication of PVA-HNT nanocomposites can be a potential way to address some of PVA's limitations. Such nanocomposites have excellent mechanical properties and thermal stability. PVA-HNT nanocomposites have been reported earlier, but without proper HNT individualization and PVA modifications. The properties of PVA-HNT for medicinal and biomedical use are attracting an increasing amount of attention for medical applications, such as wound dressings, drug delivery, targeted-tissue transportation systems, and soft biomaterial implants. The demand for alternative polymeric medical devices has also increased substantially around the world. This paper reviews individualized HNT addition along with crosslinking of PVA for various biomedical applications that have been previously reported in literature, thereby showing the attainability, modification of characteristics, and goals underlying the blending process with PVA.Entities:
Keywords: biocompatibility; biomedical application; halloysite nanotubes; polyvinyl alcohol; properties
Mesh:
Substances:
Year: 2015 PMID: 26703542 PMCID: PMC6332455 DOI: 10.3390/molecules201219884
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structural formula for PVA: (a) partially hydrolyzed; (b) fully hydrolyzed [2].
Figure 2(a) The structure of vinyl alcohol; (b) PVA is synthesized by the hydrolysis of polyvinyl acetate [26].
Figure 3TEM micrograph of HNTs [44].
Figure 4Crystalline structure of HNTs [46].
Summary of main properties.
| No. | HNTs | PVA |
|---|---|---|
| 1 | Natural, nontoxic [ | Non-toxic [ |
| 2 | Non-swelling [ | Hydrogels exhibit swelling feature in water with the peculiar characteristics of retaining water within its matrix without dissolving [ |
| 3 | Compatibility polymers oriented, such as polypropylene and polyethylene [ | PVA is more biologically compatible [ |
| 4 | Excellent mechanical properties such as tensile strength with 5 wt % HNTs increase 300% and thermal stability because HNTs are stable even at very high temperatures [ | PVA has relatively low strength and thermal stability for some applications, excellent mechanical properties such as: strength (1.6 ± 0.1 GPa), elastic modulus (48 ± 3 GPa), strain (6.5% ± 1.4%), and toughness (40 ± 6 J·g−1) [ |
| 5 | Formula [Al2Si2O5(OH)4∙nH2O] [ | Formula [-CH2CHOH-]n |
| 6 | HNT is naturally occurring, will also have the benefit to reinforce PVA and impart other biological properties to the bionanocomposites, such as drug/gene delivery capacity without fear of being carcinogenic [ | To overcome the limited biological performance and to enhance the mechanical properties of PVA, a new class of engineering designed PVA bionanocomposites has been introduced recently [ |
Uses of PVA and HNTs in non-implant and implantable devices [26,52].
| Device Type | Product PVA | Product HNTs |
|---|---|---|
| Non-implant devices | Surgical sponges and packing | Diuretic drug transportation to remove hazardous species |
| Eye wetting drops | Sustained release of drugs, food additives, and fragrances | |
| Contact lenses | Antimicrobial agents | |
| Implantable devices | Hydrophilic coatings (Catheters, leads, | Human breast cells |
| Vascular embolic agents | Fibroblasts | |
| Tissue adhesion barriers | Corrosion protection implant alloys | |
| Nerve guides | Biosensors | |
| Cartilage replacements | Used in advanced ceramic materials, especially biocompatible implants |
Figure 5The particle size and distribution of HNTs in mixture of PVA-HNTs [3].
Figure 6TEM photos of PVA-HNT nanocomposite films (2 wt % HNTs) prepared by: (a) coagulation (b) casting [3].
Figure 7TEM images of HNTs: (a) untreated and (b) after acid treatment [7].
Figure 8SEM images of fractured surfaces of PVA-HNT films after different H2SO4 treatment times (8 wt % HNT loading); (a) untreated; (b) H2SO4 treatment for 1 h and (c) H2SO4 treatment for 8 h [66].
Figure 9DSC cooling thermograms of neat PVA and PVA-HNT composite films with different HNT contents: (a) 0 wt % (neat PVA); (b) 2 wt %; (c) 10 wt %; (d) 40 wt %; (e) 53 wt % [3].
Figure 10Tg curves of PVA-HNT composites with different HNT contents [3].
Figure 11TGA curves of PVA, HNTs and PVA-HNT composites [3].
HNT-based PVA composites with the range of HNTs loading and the intended/achieved target thermal properties for each composition.
| HNTs (wt %) | Form | Property Improvements (Percentage %) | Ref. | |||
|---|---|---|---|---|---|---|
| Tc (°C) | Tg (°C) | Tm (°C) | TGA (°C) | |||
| 0, 2, 10, 40 & 53 | Film | - | 12.3 | - | 28.6 | [ |
| 0 & 10 | Film | 12 | - | 1.8 | - | [ |
| 0, 3.75, 7.5 & 15 | Modification | - | - | - | 14.3 | [ |
| 0, 5, 10 & 20 | Reinforce | - | 12.8 | 5.2 | 30 | [ |
| 0, 1, 2.5 & 5 | Reinforce | 2.6 | 3.9 | 0.5 | 8.8 | [ |
| 0, 2, 5, 7.5 & 10 | Film | - | - | 0.2 | - | [ |
| 0, 0.25, 0.5, 1, 3 & 5 | Film | - | - | - | 14.5 | [ |
Figure 12Tensile strength and Young’s modulus of PVA-HNT films with different amounts of HNTs [66].
HNT-based PVA composites with the range of HNTs loading and the intended/achieved target mechanical properties for each composition.
| HNTs (wt %) | Form | Property Improvements (Percentage %) | Ref. | ||
|---|---|---|---|---|---|
| Tensile Strength | Young’s Modulus | Elong. at Break (mm/mm) | |||
| 0, 3.75, 7.5 & 15 | Modification | 13.6 | - | - | [ |
| 0, 5, 10 & 20 | Reinforce | 22.7 | 407.1 | - | [ |
| 0, 2, 5, 7.5 & 10 | Film | 81.8 | - | - | [ |
| 0, 2, 4, 6, 8, 10 & 12 | Film | 6.4 | 80.2 | - | [ |
| 0, 0.25, 0.5, 1, 3 & 5 | Film | 20 | 94.9 | 82.9 | [ |